circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway
Author:
Funder
Natural Science Foundation of Guangxi Province
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference41 articles.
1. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016;Malzkorn;Curr. Opin. Oncol.,2016
2. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide;Mizumoto;J. Neurooncol.,2016
3. Glioblastoma: molecular pathways, stem cells and therapeutic targets;Jhanwar-Uniyal;Cancers (Basel),2015
4. Emerging role of long non-coding RNAs in cisplatin resistance;Hu;OncoTargets Ther.,2018
5. Knockdown of retinoblastoma protein may sensitize glioma cells to cisplatin through inhibition of autophagy;Liu;Neurosci. Lett.,2016
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Serum Hsa_circ_0005962 Is A Prognostic Biomarker of Paclitaxel Resistance in Nonsmall Cell Lung Cancer Treatment;International Journal of Clinical Practice;2023-10-19
2. The Glioblastoma CircularRNAome;International Journal of Molecular Sciences;2023-09-26
3. Fucoidan Enhances Cisplatin-induced Effects on SCC-25 Human Oral Cancer Cells by Inhibiting the PI3K/AKT Pathway;Anticancer Research;2023-08-30
4. The mechanisms, functions and clinical applications of miR-542–3p in human cancers;Pathology - Research and Practice;2023-08
5. Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions;Journal of Drug Delivery Science and Technology;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3